Topsail Wealth Management’s AbbVie ABBV Stock Holding History

Topsail Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Buy	4,647 +60	+1%	+$12.9K	0.15%	57
2026 Q1	$998K	Buy	4,587 +2	+0%	+$444	0.15%	52
2025 Q4	$1.05M	Buy	4,585 +1,783	+64%	+$406K	0.15%	54
2025 Q3	$649K	Buy	2,802 +1,143	+69%	+$233K	0.11%	64
2025 Q2	$308K	Sell	1,659 -28	-2%	-$5.2K	0.06%	108
2025 Q1	$353K	Buy	1,687 +33	+2%	+$6.42K	0.07%	92
2024 Q4	$294K	Buy	+1,654	New	+$304K	0.06%	91

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Topsail Wealth Management's ABBV Position: Q2 2026 in Review

Topsail Wealth Management increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $12.9K and bringing the position to 4,647 shares worth $1.17M. The position accounts for 0.15% of the portfolio, ranked #57.

Topsail Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Topsail Wealth Management held 4,647 shares of AbbVie worth $1.17M as of Q2 2026.
Topsail Wealth Management bought 60 AbbVie shares in Q2 2026, an estimated $12.9K.
AbbVie made up 0.15% of Topsail Wealth Management's portfolio in Q2 2026, its #57 holding.
Topsail Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Topsail Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.